semaglutide radnor Therapy for Wellness Services RYBELSUS® (semaglutide) tablets 7 mg

A study published in May 2024 found that men with obesity who were taking semaglutide, the active ingredient in Ozempic and Wegovy, were actually at a slightly higher risk of erectile dysfunction than men with obesity who werent taking the drug

14.2.2 Recommendations for Discontinuation Discontinuation is recommended prior to conception

Budget-conscious patients

However, no unexpected safety issues have arisen, making semaglutide a drug with an overall favorable risk/benefit profile for patients with type 2 diabetes (Smits & van Raalte, 2021)

Health Check & Lab Test Book an in-office lab draw at JustMelt or walk into any LabCorp or Quest Diagnostics Lab near you for lab testing